Daiichi, Toshiba, and Toshiba Hokuto to Develop Array-Based IVD

Jul 11, 2006

NEW YORK (GenomeWeb News) - Daiichi Pure Chemicals, Toshiba, and Toshiba Hokuto Electronics plan to co-develop microarray-based in vitro diagnostic systems and chips, the companies said today.

Under the agreement, the companies will first develop an IVD for human papilloma virus.

Daiichi Pure Chemicals and Toshiba have collaborated on the system since January 2004.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Ah, That's What It Is

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

Billions Requested

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

What to Do

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

PNAS Papers on Heart Transplant Rejection, CAR-T Profiling, Thiopurine Toxicity Variants

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.

Featured White Papers

High Throughput SPR Kinetics

Scientific Principle of Simoa (Single Molecule Array) Technology

Feb

26

Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

Mar

18

Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar

31

Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

Menu

Daiichi, Toshiba, and Toshiba Hokuto to Develop Array-Based IVD

To read the full story....

Breaking News

Veracyte Q4 Revenues Rise 31 Percent, Beat Wall Street Estimate

Capsulomics, Johns Hopkins Partner on Esophageal Cancer, Barrett's Esophagus Research

Twist Bioscience Adds Sample Prep Tech to Miroculus Automation Platform

Scipio Bioscience Raises $6.5M in Series A Financing

T2 Biosystems Q4 Revenues Jump 71 Percent, Miss Analyst Estimates

UPDATE: Exact Sciences Offering $1B of Convertible Senior Notes

The Scan

Ah, That's What It Is

Billions Requested

What to Do

PNAS Papers on Heart Transplant Rejection, CAR-T Profiling, Thiopurine Toxicity Variants

Featured White Papers

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

What's Popular?

ReadCoor Launches Spatial Multiomics Platform at AGBT

Sponsorships